Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.63 Billion | USD 3.13 Billion | 7.48% | 2023 |
Zion Market Research has published a report on the global Anti-Snoring Devices And Snoring Surgery Market, estimating its value at USD 1.63 Billion in 2023, with projections indicating that it will reach USD 3.13 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 7.48% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Anti-Snoring Devices And Snoring Surgery Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
A slight obstruction of the airway causes snoring. Muscles in the lower jaw, throat, and tongue relax during sleep. These muscles can slip into the back of the throat and partly block the airway if they relax too much. The vibrating soft tissues are caused by the air flowing into the airway. The harsh, clicking sound created by snoring is caused by these vibrations. Snoring is considered to deprive snorers and others around them of sleep, as well as daytime drowsiness, irritability, loss of concentration. Anti-snoring systems aid in the elimination of blocked airways.
When chronic snoring is ignored for an extended amount of time, it may lead to sleep apnea, stroke, diastolic or systolic systemic hypertension, cardiac atrial fibrillation, interventional coronary artery disease, and other complications. The only treatment choices are various anti-snoring instruments and anti-snoring surgery. The rising prevalence of sleep problems including sleep apnea is projected to be the main driver of the anti-snoring system industry.
The recent increase in alcohol intake and cigarette smoking is the primary factor driving the growth of the anti-snoring system and snoring surgery markets. Furthermore, an increase in the obese and elderly population is one of the primary factors driving the growth of the anti-snoring system and snoring surgery markets.
Anti-snoring devices such as nasal devices and mandibular advancement devices (MAD) are becoming more common as people become more aware of sleep disturbances, which will boost the anti-snoring devices industry upward. The high cost of anti-snoring devices and snoring surgery can hamper the growth of the anti-snoring device and snoring surgery markets.
Based on device types, the Anti-Snoring Devices and Snoring Surgery market is divided as Mandibular Advancement Devices, Tongue Stabilizing Device, Continuous Positive Airway Pressure Devices and others. The Sub-segment of Continuous Positive Airway Pressure (CPAP) Devices is expected to have the largest market share. In the wake of current Covid-19 pandemic, demand for CPAP machines and masks is expected to increase, as CPAP devices have been shown to help manage COVID-19 symptoms including breathing difficulty.
Based on application, Anti-Snoring Devices and Snoring Surgery market is segmented into Somnoplasty, Uvulopalatopharyngoplasty Surgery, Tonsillectomy and Adenoidectomy Surgery, Maxillo-mandibular & Genioglossus Advancement Surgeries, Radiofrequency Ablation Surgery and Others.
Report Attributes | Report Details |
---|---|
Report Name | Anti-Snoring Devices And Snoring Surgery Market |
Market Size in 2023 | USD 1.63 Billion |
Market Forecast in 2032 | USD 3.13 Billion |
Growth Rate | CAGR of 7.48% |
Number of Pages | 140 |
Key Companies Covered | Thermo Fisher Scientific, Inc., Associates of Cape Cod, Inc., Charles River Laboratories, Inc., Ellab A/S, Genscript, Hyglos GmbH, Lonza Group, Merck Kgaa, WUXI Pharmatech (Cayman) Inc. and Wako Chemicals Usa, Inc. |
Segments Covered | By Product, By Test, By Application and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Based on geographies, the global anti-snoring devices and snoring surgery market are segmented into five types: North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. These segments are further sub-segmented into U.S., U.K., Germany, France, China, Japan, India, and Brazil. North America accounted for the largest market share of the global anti-snoring device and snoring surgery market in terms of revenue followed by Europe. The growth is attributed due to rising awareness related to health care in this region.
Some of the major players of global Anti-Snoring Devices and Snoring Surgery market includes
By Device Type
By Application
By Region
FrequentlyAsked Questions
Zion Market Research has published a report on the global Anti-Snoring Devices And Snoring Surgery Market, estimating its value at USD 1.63 Billion in 2023, with projections indicating that it will reach USD 3.13 Billion by 2032.
The market is expected to expand at a compound annual growth rate (CAGR) of 7.48% over the forecast period 2024-2032.
The recent increase in alcohol intake and cigarette smoking is the primary factor driving the growth of the anti-snoring system and snoring surgery markets. Furthermore, an increase in the obese and elderly population is one of the primary factors driving the growth of the anti-snoring system and snoring surgery markets.
Because of the advancement of revolutionary anti-snoring gadgets in the healthcare industry, North America dominated the anti-snoring system and snoring surgery market in terms of revenue. Furthermore, the anti-snoring system and snoring surgery markets have significant growth potential in Asia Pacific's developing economies, owing to rising disposable income and a rise in awareness.
Some of the major players of global Anti-Snoring Devices and Snoring Surgery market includesSleeping Well, LLC, Apnea Sciences Corporation, The Pure Sleep Company, Somnomed Limited , Airway Management Inc., Theravent, Inc., Tomed Dr. Toussaint Gmbh, Glaxosmithkline, PLC and Meditas Ltd. among others .
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed